Epidemiological, histopathological, and immunohistochemical profile of ovarian tumors in women in the North-Central Algeria

I n t r o d u c t i o n . Ovarian tumors (OT) are the leading cause of death from gynecological cancer.

A i m .   Studying of epidemiological, histopathological, and immunohistochemical profile of OT in the North-Central region of Algeria.

M a t e r i a l s   a n d   m e t h o d s .  An epidemiological and histopathological analysis of OT that were diagnosed over a period of 32 months from January 2018 to August 2020 in Algiers was carried out. It grouped all the histologically confirmed cases in the Pathological Anatomy and Cytology Department of the Hussein Dey Hospital during the study period. Through this work, we collected 110 cases of OT. Among this total, 26 cases (23.63%) were represented by functional cysts and 7 cases (6.36%) by borderline epithelial tumors excluded from our work. Only OT (benign and malignant) were studied. On the epidemiological level, we were interested in the age factors and distribution by year of study, and on the anatomopathological level, we dealt with the topography, macroscopic and histological aspects of these tumors.

R e s u l t s .  An average age of the patients with OT was 39.99 years, with extremes of 16 years and 88 years, and the most affected age was that of 15–30 years with 29 cases. Both ovaries were affected in 4.47% of cases. The study revealed that 79% of OT were benign, and epithelial tumors were more frequent (69% of cases). In this type, serous cystadenoma was most common among benign epithelial tumors (70.45%), and cystadenocarcinoma was most dominant among malignant epithelial tumors (80%). Mature teratoma represented 85.71% of germ cell tumors in our series, and fibrothecoma represented 55.55% of sex cord-stromal tumors cases. The latter predominated in older patients (46–60 years.

C o n c l u s i o n .  The authors recommend to broaden this study over several hospital structures with the inclusion of other parameters for a better understanding and determining the criteria of this disease.

1. Taylan E., Oktay K. Fertility preservation in gynecologic cancers. Gynecol. Oncol. 2019;155(3):522–529. DOI: 10.1016/j.ygyno.2019.09.12.

2. Osmers R. Sonographic evaluation of ovarian masses and its therapeutic implications. Ultrasound Obstetric Gynecol. 1996;8(4):217–222. DOI: 10.1046/j.1469-0705.1996.08040217.x.

3. Querleu D. Tumeurs de l’ovaire: classification et histopathologie. EMC Gynécol. 1993;680-A-10:6.

4. Al-Dossary A.A., Tawfik E.A. Isichei A.C. et al. Engineered EV-mimetic nanoparticles as therapeutic delivery vehicles for high-grade serous ovarian cancer. Cancers. 2021;13(12):3075. DOI: 10.3390/cancers13123075.

5. Gentry-Maharaj A., Menon U. Screening for ovarian cancer in the general population. Best. Pract. Res. Clin. Obstet. Gynaecol. 2012;26(2):243–256. DOI: 10.1016/j.bpobgyn.2011.11.006.

6. Książek K. Molecular biology of ovarian cancer: from mechanisms of intraperitoneal metastasis to therapeutic opportunities. Cancers (Basel). 2021;13(7):1661. DOI: 10.3390/cancers13071661.

7. Zilfi W. (2012). Les tumeurs de l’ovaire : aspects épidémiologiques, diagnostiques et thérapeutiques. Thèse de médecine Maroc. Université Cadi Ayyad. 94 p.

8. Toufouti A., Adjimi D. (2014). Cancer de l’ovaire (Epidémiologie). Mémoire de master soutenu publiquement à l’Université de Constantine.

9. Hamdi Charif M., Bidoli E., Birri S. et al. Cancer estimation of incidence and survival in Algeria. J. Cancer. Res. Ther. 2015;3(19):100–104. DOI:10.14312/2052-4994.2015-14.

10. WHO Classification of Tumours. 5th ed. Female Genital Tumours / WHO Classification of Tumours Editorial Board (2020). IARC: Lyon, France. Vol. 4.

11. Berek J.S., Kehoe S.T., Kumar L., Friedlander M. Cancer of the ovary, fallopian tube, and peritoneum. Int. J. Gynaecol. Obstet. 2018;143(2):59–78. DOI:10.1002/ijgo.12614.

12. Salvetti N.R., Stangaferro M.L., Palomar M.M. et al. Cell proliferation and survival mechanisms underlying the abnormal persistence of follicular cysts in bovines with cystic ovarian disease induced by ACTH. Anim. Reprod. Sci. 2010;122(1-2):98–110.

13. Mimoune N., Benaissa M.H., Baazizi R. et al. Histological and immune-histochemical evaluation of ovarian cysts in cattle. Ruminant Sci. 2020;9(1):1–6.

14. Traoré H. (2019). Tumeurs de l’ovaire: aspects épidémiologiques et anatomopathologiques dans le service de Cytologie et d’Anatomie pathologiques au Mali. Thèse de Médecine USTTB. P. 20.

15. Ndamba Engbang J.P., Koh V.M., Tchente C.N., Fewou A. Aspects histo-épidémiologiques des cancers génitaux de la femme dans la région du Littoral, Cameroun // Pan African Med. J. 2015;21(116) :16. DOI:10.11604/pamj.2015.21.116.6755. (In French.)

16. El-Harrak M. Education thérapeutique des patients atteints de cancer. Thèse de Doctorat en Pharmacie. Univ. Mohamed V, Faculté de médecine et de pharmacie, Rabat. Maroc., 2016. P. 39.

17. Javed I., Aurangzaib A., Azra N., Afshan S. Pattern of ovarian pathologies // J. Rawalpindi Med. Coll. 2013;17(1):113–115.

18. Bagayogo M. Tumeurs ovariennes : Aspects épidémiologiques, cliniques, histologiques et Thérapeutiques dans le service de Gynécologie-Obstétrique du CHU Gabriel TOURE. Thèse de Médecine. USTT-B-16-M., 2019. 89 p.

19. Haroon S., Zia A., Idrees R. et al. Clinicopathological spectrum of ovarian sex cord-stromal tumors; 20 years’ retrospective study in a developing country // J. Ovarian Res. 2013;6:87. DOI:10.1186/1757-2215-6-87.

20. Bast R.C., Hennessy B., Mills G.B. The biology of ovarian cancer: New opportunities for translation // Nature Rev. Cancer. 2009;9(6):415–428. DOI:10.1038/nrc2644.